<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="533">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 16, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04344327</url>
  </required_header>
  <id_info>
    <org_study_id>2020-02</org_study_id>
    <nct_id>NCT04344327</nct_id>
  </id_info>
  <brief_title>COVID-19 in Cardiology Unit in France : Risk Factors for Mortality (CCF)</brief_title>
  <acronym>CCF</acronym>
  <official_title>SARS-CoV2 in Cardiology Unit in France : Risk Factors for Mortality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French Cardiology Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>French Cardiology Society</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The COVID-19 pandemic of SARS CoV2 (Severe Acute Respiratory Syndrome, COVID-19) infection,
      which is currently evolving in France, raises many questions about the clinical and
      biological profile of infected hospitalized patients. If certain biological factors like
      troponin, BNP (Brain Natriuretic Peptid), or clinical factors like cardiovascular history or
      oncological history are associated with a worse prognosis, available data comes from studies
      in Asia for the majority, or including a limited number of patients. Patient stratification
      remains a major issue for patient sorting and early referral of patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is observational, multicenter and retrospective, and is conducted in hospitals in
      France.

      Clinical data relating to history, comorbidities, risk factors, previous treatments,
      treatments during the hospitalization and treatments at the discharge from hospital, clinical
      parameters, biological and ultrasound cardiological data, procedures and events during
      hospitalization will be recorded, in order to identify the early predictors of clinical
      worsening in patients hospitalized for COVID-19 in cardiology or conventional medicine
      department.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 10, 2020</start_date>
  <completion_date type="Anticipated">July 9, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 19, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Death rate</measure>
    <time_frame>Through study completion, an average of 4 weeks</time_frame>
    <description>Survival analysis (all-cause death) in relation with clinical patient profile</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Transfer to intensive care unit</measure>
    <time_frame>Through study completion, an average of 4 weeks</time_frame>
    <description>Correlation between clinical patient profile and transfer need to intensive care unit</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventilation analysis</measure>
    <time_frame>Through study completion, an average of 4 weeks</time_frame>
    <description>Type of ventilation procedures needed during the hospitalization (Orotracheal intubation for mechanical ventilation or Non-invasive ventilation or 29/5000 high flow oxygen therapy - Optiflow) in relation with clinical patient profile</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Construction of a predictive score for COVID-19 severe form</measure>
    <time_frame>Through study completion, an average of 4 weeks</time_frame>
    <description>Description of clinical and biological patient profile leading to a worse prognosis</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Infection Viral</condition>
  <condition>Infection, Hospital</condition>
  <condition>COVID</condition>
  <arm_group>
    <arm_group_label>Patients with COVID-19</arm_group_label>
    <description>Patients hospitalized in conventional sector with diagnosis of COVID-19 (positive PCR (Polymerase Chain Reaction) or diagnosis presumed by the clinical and radiographic picture)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting to the hospital with COVID-19 infection
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Patients hospitalized in cardiology unit or medicine conventional sector with diagnosis
        of COVID-19 (positive PCR (Polymerase Chain Reaction) or diagnosis presumed by the clinical
        and radiographic picture)

        Exclusion Criteria:

          -  Minors

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillaume BONNET, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hopital Européen Georges Pompidou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Orianne WEIZMAN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nancy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guillaume BONNET, MD</last_name>
    <phone>+33 6 22 70 15 01</phone>
    <email>guillaume.bonnetccf@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tessa BERGOT</last_name>
    <phone>+33 1 44 90 70 33</phone>
    <email>tessa.bergot@sfcardio.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Lille</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Clémence DOCQ</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHM</name>
      <address>
        <city>Marseille</city>
        <zip>13000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vassili PANAGIDES, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Massy</name>
      <address>
        <city>Massy</city>
        <zip>91300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandre GAUTIER, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP - Bichat</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arthur DARMON, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aphp - Hegp</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume BONNET, MD</last_name>
      <email>guillaume.bonnetccf@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Joffrey CELLIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IMM</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie RIBEYROLLES, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corentin CHAUMONT, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonin TRIMAILLE, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clément KARSENTY, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nancy</name>
      <address>
        <city>Vandœuvre-lès-Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Orianne WEIZMAN, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 9, 2020</study_first_submitted>
  <study_first_submitted_qc>April 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2020</study_first_posted>
  <last_update_submitted>April 13, 2020</last_update_submitted>
  <last_update_submitted_qc>April 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiology department</keyword>
  <keyword>Medicine conventional department</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Cross Infection</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

